Medical Imaging & PACS
The buyer population — Medical and diagnostic laboratories
Base industry report for 621510 →- Establishments · CanadaA
- 2,470
- Under 10 employeesA
- 65%
Of 2,470 Canadian establishments with employees, 65% have fewer than ten — mostly small operators. Each of those is one potential account, before any filter for size or fit.
Entry signal — what decides who wins here
Structure decidesThe binding constraint is not executional. Being better than the incumbent does not, by itself, get you in — this one is cleared with capital, an asset, or a permission.
Raise or borrow the entry ticket, or buy an operator who has already paid it. The barrier is money rather than permission, so it yields to a balance sheet — and an acquisition is usually cheaper than a start.
Measured, not forecast: the share of US establishments opening in one year that were still active later. It counts good operators and bad ones together, which is exactly why it is the honest answer to “what are the odds”. It is for the whole sector rather than this market, and the ten-year figure comes from an older cohort because no younger one has reached ten years.
This is not a probability of success, and it is not a verdict on you. No survival probability is published per market, and inventing one would be worse than saying so. What the bar reads is how much of the outcome sits inside an operator's control: green means the hurdles are ones a better operator clears, red means the binding constraint is capital, an asset or a permission rather than execution. Someone arriving with an advantage this screen did not assume can win a market shown in red.
Companies named in this market · 6
The binding constraint — entry cost
Software attached to imaging hardware — the same razor-and-blade structure that decided the veterinary study, with a regulatory floor on top: PACS and any diagnostic AI are regulated medical devices requiring FDA clearance or Health Canada licensing. Capital and clearance timelines both sit outside a small entrant's runway. Sourced update: the money in this market is in the scanners, not the software. GE HealthCare's imaging line alone is $9.24B and Philips' Diagnosis & Treatment €8.5B, while the leading independent imaging-IT vendor, Sectra, turns over roughly a tenth of that — and its growth is in cloud recurring revenue, up 49%.
Sectors joined: Diagnostics · Diagnostics/Biotech · Biotech Diagnostics · PCR Diagnostics · Healthtech - Ophthalmic Diagnostics
[UNVERIFIED] Sector-to-NAICS mapping is analyst judgment — see data/angel-sector-map.json. Counts are a per-record cross-reference and are not additive across records.
The incumbent
Who owns this market and who is coming for it. Fields a screen never reached say so rather than guessing.
Financials & market size — sourced
Figures that came from a filing, a results release or reputable reporting, each carrying its evidence tier.
Market size, derived
Built from the competitor set upward rather than quoted from a forecast. Published TAMs in these categories are frequently reverse-engineered from each other, so any published figure is checked against the vendor arithmetic rather than trusted on its own.
Disclosed revenue from 2 of 4 named vendors. The market is at least this large.
No vendor has both a disclosed revenue and a published share.
Only a revenue floor is known — the true market is larger by whatever the undisclosed vendors earn.
Competitor set · 4 named · 2 disclose revenue
| Name | Revenue | Share | Note |
|---|---|---|---|
| GE HealthCare (imaging)NASDAQ: GEHCB | $9.2B | — | 2025 imaging revenue — scanners and modalities, not PACS software |
| Philips (Diagnosis & Treatment)NYSE: PHGA | $8.5B | — | 2025 segment revenue in EUR — imaging systems, broader than imaging IT |
| SectraSTO: SECT BA | not disclosed | — | FY2024/25 net sales SEK 3,239.8M (~$310M) — reported in SEK and deliberately not converted into the floor |
| Fujifilm (Synapse) / Agfa / Merative (Merge)C | not disclosed | — | Not separately disclosed at imaging-IT level |
Evidence
Evidence. Incumbent financials on this record ARE sourced (tier A/B, see the financials block). The cut factor and reasoning remain analyst judgment and were not tested against customers.
Where the industry talks
The associations, forums and events where people in this trade actually talk shop — where to listen before entering, and where the first customers are found. Each link was opened on the date shown.
The PACS-administrator and imaging-informatics society; runs the CIIP certification and the National Imaging Informatics Course. No member count on its site.
SIIM 2027, Nashville. The vendor floor for PACS, VNA and imaging-AI software; abstracts open now, registration opens Jan 2027.
Radiologist society and publisher of Radiology; runs the RSNA Imaging AI Certificate. No member count stated on its About or Membership pages.
The largest radiology trade show in the world (Chicago, each late November); every PACS and imaging-AI vendor exhibits. No attendance figure on the page.
National specialty association for radiologists; accreditation programmes, practice guidelines and an Annual Scientific Meeting. No member count on its site.
MRT members ('over 11,000') per its Membership page. The technologists who operate the modalities and PACS workstations day to day.
Daily radiology and imaging-IT news (articles dated Sept 22, 2026), including PACS and FDA clearances. Blocks curl but loads via a browser fetch; its old discussion forums are no longer visible.
Trade magazine covering imaging hardware and enterprise imaging/PACS, with a buyer's guide and comparison charts.
Radiology Business (radiologybusiness.com) blocks automated access and was not verified by search, so it is omitted.
The businesses it sells to
Operating-business records filed along the same branch of NAICS — the customers of this software, screened as businesses in their own right.